The clinicopathological features of patients with membranous nephropathy
暂无分享,去创建一个
Q. Han | Dong Zhang | Hanyu Zhu | Xiangmei Chen | Yong Wang | Jing Gao | Wenjia Geng | Xiaoli Yang
[1] B. Liu,et al. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy , 2017, Scientific Reports.
[2] Bo Chen,et al. Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy , 2017, Scientific Reports.
[3] Lin Sun,et al. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy]. , 2017, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.
[4] C. Hao,et al. Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy , 2017, Chinese medical journal.
[5] F. Cosio,et al. Recurrent Membranous Nephropathy After Kidney Transplantation: Treatment and Long-Term Implications , 2016, Transplantation.
[6] H. Debiec,et al. Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients. , 2015, Molecular immunology.
[7] J. Klein,et al. Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy , 2015, Proteomics.
[8] H. Debiec,et al. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care , 2015, The Lancet.
[9] Y. Wang,et al. Clinicopathological analysis of idiopathic membranous nephropathy in young adults. , 2015, Genetics and molecular research : GMR.
[10] C. Greenfeld,et al. Overview of Current and Alternative Therapies for Idiopathic Membranous Nephropathy , 2015, Pharmacotherapy.
[11] Huhai Zhang,et al. Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis , 2015, Scientific Reports.
[12] J. Klein,et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. , 2015, The New England journal of medicine.
[13] U. Panzer,et al. M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[14] M. Ando,et al. Patient Age and the Prognosis of Idiopathic Membranous Nephropathy , 2014, PloS one.
[15] Javier Zamora,et al. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. , 2014, The Cochrane database of systematic reviews.
[16] U. Panzer,et al. PLA2R Antibody Levels and Clinical Outcome in Patients with Membranous Nephropathy and Non-Nephrotic Range Proteinuria under Treatment with Inhibitors of the Renin-Angiotensin System , 2014, PloS one.
[17] H. Debiec,et al. Immunopathogenesis of membranous nephropathy: an update , 2014, Seminars in Immunopathology.
[18] C. Ponticelli,et al. Glomerular diseases: membranous nephropathy--a modern view. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[19] T. Muthukumar,et al. Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy , 2014, Journal of Nephrology.
[20] J. Wetzels,et al. Treatment of idiopathic membranous nephropathy , 2013, Nature Reviews Nephrology.
[21] L. Beck,et al. Membranous nephropathy: not just a disease for adults , 2013, Pediatric Nephrology.
[22] M. Praga,et al. Glomerular disease: Predicting outcomes in idiopathic membranous nephropathy , 2012, Nature Reviews Nephrology.
[23] D. Yang,et al. Elevated Levels of Immunoglobulin E May Indicate Steroid Resistance or Relapse in Adult Primary Nephrotic Syndrome, Especially in Minimal Change Nephrotic Syndrome , 2011, The Journal of international medical research.
[24] J. Lewis,et al. Membranous nephropathy with crescents. , 2011, Journal of the American Society of Nephrology : JASN.
[25] G. Remuzzi,et al. Membranous nephropathy associated with IgG4-related disease. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] A. Cybulsky. Membranous nephropathy. , 2011, Contributions to nephrology.
[27] 克治 桑門. 海外論文紹介 : M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy , 2010 .
[28] C. Ponticelli,et al. Management of idiopathic membranous nephropathy , 2010, Expert opinion on pharmacotherapy.
[29] C. Ponticelli,et al. Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy? , 2010, Journal of nephrology.
[30] David M. Beck,et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.
[31] 刘双信,et al. Membranous nephropathy , 2008 .
[32] Zhi-Hong Liu,et al. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. , 2004, Kidney international.
[33] N. Yorioka,et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. , 2004, Kidney international.
[34] F. Salvatore,et al. Gender and the progression of chronic renal diseases: does apoptosis make the difference? , 2004, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.
[35] Kuender D Yang,et al. Implication of serum IgE in childhood nephrotic syndrome , 2003, Pediatric Nephrology.
[36] T. Miyawaki,et al. Clinicopathological characteristics of the focal and segmental form of idiopathic membranous nephropathy: Comparison with the typical form of this disease , 1997, Acta paediatrica Japonica : Overseas edition.